All In Biotech

Drug Trial Radar · NCT06126380

Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

AT-1501-K209: BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

Last checked: Nov 19, 2026Latest source record: Dec 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

132

Planned (sponsor's estimate)

Start

Oct 25, 2023

Primary completion

Dec 2029

Study completion Dec 2029

Sponsor

Lead sponsor
Eledon PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Nov 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the long term safety and efficacy of AT-1501 (tegoprubart) compared with tacrolimus in patients undergoing kidney transplantation.

Conditions

  • Kidney Transplant Rejection

Interventions

  • AT-1501Drug

    AT-1501 20 mg/kg administered every 3 weeks IV + MMF 1000 mg PO twice daily (BID) or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO once daily (QD) or equivalent

  • TacrolimusDrug

    Tacrolimus dosed PO BID with the dose titrated to maintain a trough concentration of 6-8 ng/mL+ MMF 1000 mg PO BID or MPS 720 mg PO BID + Corticosteroids 5 mg of prednisone PO QD or equivalent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and Tolerability - Incidence of Treatment Emergent Adverse EventsTime frame: Assessed from date of enrollment through Month 48
  2. Safety and Tolerability - Kidney Transplant Medication Side EffectsTime frame: Assessed from date of enrollment through Month 48

Locations

43 sites in 8 countries. Site status is shown where the registry gives one.

  • University of California Los Angeles

    Los Angeles, California

  • Keck School of Medicine of USC

    Los Angeles, California

  • University of California, Irvine Medical Center

    Orange, California

  • University of California, Davis Medical Center

    Sacramento, California

  • Jacobs Medical Center at UC San Diego Health

    San Diego, California

  • MedStar Georgetown University Hospital

    Washington D.C., District of Columbia

  • Tampa General Hospital

    Tampa, Florida

  • Emory University Hospital

    Atlanta, Georgia

  • Augusta University

    Augusta, Georgia

  • University of Chicago

    Chicago, Illinois

  • Loyola University Medical Center

    Maywood, Illinois

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Tulane Medical Center

    New Orleans, Louisiana

  • John Hopkins University

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Henry Ford Health System

    Detroit, Michigan

  • University of Minnesota Medical Center

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University in St. Louis

    St Louis, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • New York University Langone Health - Tisch Hospital

    New York, New York

  • Duke University Medical Center

    Durham, North Carolina

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • University of Pittsburgh Medical Center

    Harrisburg, Pennsylvania

  • UT Southwestern

    Dallas, Texas

  • Virginia Commonwealth University

    Richmond, Virginia

  • Royal Adelaide Hospital

    Adelaide, South Australia, Australia

  • Fiona Stanley Hospital

    Perth, Western Australia, Australia

  • Fundação Oswaldo Ramos - Hospital do Rim

    São Paulo, Brazil

  • Hospital das Clínicas da Faculdade de Medicina de São Paulo

    São Paulo, Brazil

  • St. Paul's Hospital

    Vancouver, British Columbia, Canada

  • McGill University Health Care Centre

    Montreal, Quebec, Canada

  • Groupe Hospitalier Pellegrin

    Bordeaux, France

  • CHU Grenoble-Alpes - Hopital Nord Michallon

    Grenoble, France

  • Centre Hospitalier Universitaire Dupuytren

    Limoges, France

  • CHU de Toulouse - Hopital de Rangueil

    Toulouse, France

  • Charite Universitatsmedizin Berlin

    Berlin, Germany

  • Hospital del Mar - Parc de Salut Mar

    Barcelona, Spain

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spain

  • Hospital Clinical de Barcelona

    Barcelona, Spain

Showing 40 of 43 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.